Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

China Pioneer to Provide NeutroPhase for Free to Patients with Flesh-Eating Disease

publication date: Dec 16, 2014
China Pioneer Pharma will offer NeutroPhase, a topical skin and wound antimicrobial product, in China free of charge to patients with flesh-eating disease (necrotizing fasciitis). The offer is underwritten by the US-based National Necrotizing Fasciitis Foundation. China Pioneer distributes NeutroPhase in China for NovaBay Pharma of the US, and last year, it made a $5.7 million investment in NovaBay to secure China rights to its products. More details....

Stock Symbol: (HK: 1345)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital